Transform Weight Loss
Transform Weight Loss is a multi-modality weight management medical practice offering GLP-1 medications, bariatric surgery (including the proprietary MagnaSlim procedure), cosmetic, and women's health services across two Pacific Northwest clinics and an outpatient surgery center, serving individual consumers via direct-to-consumer channels.
- Company typePrivate
- Founded2018
- HeadquartersKirkland, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Transform Weight Loss does
Transform Weight Loss is a multi-modality weight management medical practice founded in 2018 by Dr. Peter Billing in Lynnwood, Washington. The practice operates two clinic locations (Lynnwood and Kirkland) plus an ambulatory surgery center (ASC) in Edmonds opened in 2022, and delivers an integrated portfolio spanning non-surgical medical weight loss (GLP-1 medications including Ozempic, Wegovy, Mounjaro, and Zepbound), bariatric surgery (gastric sleeve, gastric bypass, SADI-S, gastric balloon, Lap-Band, and the proprietary MagnaSlim magnetic compression procedure), cosmetic body contouring, GI, and women's health services (via the forthcoming Transform Women's Health vertical). The organization employs 11-50 staff and operates alongside Transform At Home, a telehealth platform that extends clinical reach beyond the physical footprint.
The practice's core technical differentiator is MagnaSlim, a proprietary magnetic compression bypass procedure developed in-house, supplemented by exclusive partnerships with Spatz3 (adjustable gastric balloon) and ReShape (Lap-Band). The Edmonds ASC provides outpatient surgical infrastructure that lowers the cost of delivery versus hospital-based bariatric surgery, and the multi-specialty staffing model allows the practice to bundle surgical, medical, cosmetic, and women's health services within a single patient relationship.
The business model is direct-to-consumer with inside-sales support. Revenue is generated through high-ticket one-time surgical fees, recurring GLP-1 subscription revenue, cosmetic procedure fees, and ancillary services. Patient financing is enabled through partnerships such as Cherry Financing, reducing out-of-pocket friction for higher-ticket surgical bundles. There are no disclosed enterprise or B2B customer relationships; all revenue derives from individual patient transactions across the Pacific Northwest market.
Transform Weight Loss firmographics
Firmographics- Name
- Transform Weight Loss
- Legal name
- Transform Weight Loss, LLC
- Website
- https://transformweightloss.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Transform Weight Loss is a multi-modality weight management medical practice offering GLP-1 medications, bariatric surgery (including the proprietary MagnaSlim procedure), cosmetic, and women's health services across two Pacific Northwest clinics and an outpatient surgery center, serving individual consumers via direct-to-consumer channels.
- Ownership category
- akta.pro rank
Transform Weight Loss industry classification
Industry- Product category
- Medical Weight Loss and Bariatric Surgery Services
- NAICS
- Offices of Physicians (6211), Ambulatory Health Care Services (621), Diet and Weight Reducing Centers (812191)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro industry
- Obesity Medicine & Weight Management
Keywords
Where Transform Weight Loss is headquartered
LocationHeadquarters
- HQ city
- Kirkland
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Transform Weight Loss business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Surgical Weight Loss Procedures: Revenue from surgical procedures including gastric sleeve, gastric bypass, MagnaSlim, SADI, gastric balloon, and lap band procedures performed at their ambulatory surgery center.
- Non-Surgical Medical Weight Loss: Revenue from medically-supervised weight loss programs including medications (GLP-1 agonists), supplements, nutritional consulting, biometric testing, and Transform At Home telehealth services.
- Weight Loss Medications: Revenue from prescription weight loss medications including Ozempic, Wegovy, Mounjaro, and Zepbound as part of medically-supervised programs.
- Cosmetic Procedures: Revenue from body contouring procedures including liposuction, tummy tuck, arm contouring, thigh contouring, and breast augmentations performed by Dr. Eric Harris.
- Supplements: Revenue from vitamins and supplements sold through Bariatric Advantage partnership to support weight loss journey.
- GYN Services: Revenue from gynecological services including endometriosis treatment, fibroid management, hysterectomy, Essure removal, and other GYN surgeries under Dr. Richard Rosenfield.
- Cherry Financing Partnership: Partnership with Cherry Technologies for patient financing options, enabling patients to pay for procedures over time with 0% APR and other promotional rates.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Summer Wellness Package - 3-month comprehensive weight loss plan |
| Unit Pricing | Pay-as-you-go | DEXA Body Composition Scan - Special Weekend Pricing |
| Other | Monthly | Cherry Financing Payment Plans |
| One time/ perpetual license | Pay-as-you-go | Gastric Balloon Procedure |
| One time/ perpetual license | Pay-as-you-go | MagnaSlim Procedure |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels10 records
Transform Weight Loss product offering
Product offeringCore offering
Transform Weight Loss is a medical practice that provides a comprehensive spectrum of weight loss and wellness services to individuals, ranging from non-surgical medically-supervised programs (GLP-1 medications, biometric testing, nutritional consulting, supplements) and surgical bariatric procedures (gastric sleeve, gastric bypass, gastric balloon, Lap Band, SADI, and the proprietary MagnaSlim magnetic compression procedure) to cosmetic body contouring and gynecological/GI surgical services. Services are delivered at two Washington State clinics and an ambulatory surgery center, plus a telehealth platform (Transform at Home) for virtual consultations, medications, and ongoing coaching.
Product overview
Transform Weight Loss is a comprehensive weight loss center offering a multi-faceted approach to weight management. The portfolio consists of three main pillars: non-surgical medical weight loss (Transform at Home program with medications like Ozempic, Wegovy, Mounjaro, ZepBound, plus biometric testing, nutritional consulting, supplements, and app tracking), surgical weight loss procedures (gastric sleeve, gastric bypass, gastric balloon, Lap Band, MagnaSlim magnetic compression procedure, SADI surgery, and hernia repair), and cosmetic body contouring (liposuction, tummy tuck, arm/thigh contouring, breast augmentation). Additionally, the practice offers gastrointestinal services (gastroparesis, TIF procedure) and gynecological services under Transform Women's Health (endometriosis, fibroids, hysterectomy). All medical weight loss services are available in-person at Lynnwood and Kirkland, WA locations or via virtual Transform at Home telehealth platform. Surgical procedures are performed at the ambulatory surgery center in Edmonds, WA.
Differentiator
Problem solved
Functional benefit
Brands
- Transform at Home: Telehealth-based weight loss program offering medications, nutritional consulting, biometric testing, supplements, and app tracking technology.
- Transform Cosmetic
- Transform Women's Health
Quantifiable outcome
- 70-80% of excess weight loss within 12-18 months with MagnaSlim procedure
- +6 more outcomes
Companies that use Transform Weight Loss
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles5 records
Transform Weight Loss technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature5 records
Transform Weight Loss partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered minor and core.
- Box of GoodminorPartnership providing Transform patients with 25% discount on produce boxes using coupon code TRANSFORM25. Supports healthy eating as part of weight loss journey.
- IFSO (International Federation for Surgery of Obesity)minorTransform Weight Loss presented at the IFSO 2025 annual meeting in Santiago, Chile. Dr. Eric Harris presented on post-bariatric cosmetic surgery while Dr. Peter Billing shared case series on ambulatory bariatric surgery advancements. Conference brought together 3,000+ colleagues from over 70 national societies.
- Naomi's VillageminorKenyan orphanage and school serving 500 children. Transform staff (including Dr. Billing) traveled to Kenya on mission trip, providing surgical equipment to Kijabe Hospital and community support including food packages and supplies.
- ReShape Lifesciences (Lap-Band)coreReShape Lifesciences acquired the Lap-Band System and partnered with Transform Weight Loss to relaunch Lap-Band placements in Washington State. Transform is the ONLY program in Washington offering Lap-Band placement. Dr. Billing has been placing gastric bands since 2003.
- Bariatric AdvantageminorBariatric Advantage provides vitamins and supplements for weight loss patients. Transform offers supplements through their website using Bariatric Advantage's platform at transformweightloss.bariatricadvantage.com.
- MedtronicminorDr. Billing serves as a consultant for Medtronic regarding ambulatory bariatric surgery. Medtronic is a major medical device company.
- EthiconminorDr. Billing serves as a consultant for Ethicon regarding ambulatory bariatric surgery. Ethicon is a Johnson & Johnson medical devices company.
- Spatz MedicalcoreTransform Weight Loss partnered with Spatz Medical to offer the Spatz3 adjustable gastric balloon. Transform was chosen from a handful of centers in the U.S. to launch this innovative technology. They were the FIRST bariatric center in the Northwest to offer the Spatz3 Gastric Balloon.
Scale indicators6 records
Recent moves10 records
Expansion highlights6 records
Transform Weight Loss competitors and assessment
Company assessmentDirect peers
- Ro: Direct-to-patient telehealth provider with a weight loss program offering GLP-1 medications paired with coaching and tracking, comparable to Transform at Home in delivery model and target consumer.
- Noom: Digital health platform offering behavior-change weight management with optional medication support; comparable to Transform's coaching, nutrition, and app-tracking layer, though without surgical offering.
- Found: Subscription weight loss platform combining medication access with coaching and behavior change; overlaps directly with Transform's medically-supervised non-surgical program and consumer acquisition motion.
- Calibrate: Telehealth metabolic health company combining GLP-1 prescribing with lifestyle coaching; directly competes for the same medically-supervised weight loss consumer that Transform at Home targets.
- Hims & Hers Health: National telehealth platform offering GLP-1 weight loss programs with subscriptions and consumer-grade onboarding; directly competes with Transform at Home for medically-supervised weight loss patients seeking non-surgical solutions.
Broad incumbents
- Novo Nordisk: Manufacturer of semaglutide (Ozempic, Wegovy) prescribed through Transform at Home; a broad incumbent whose drug supply, pricing, and direct channels directly affect Transform's medical weight loss prescribing volume and margin.
- NYU Langone Weight Management Program: Academic medical center offering comprehensive bariatric surgery and medical weight management comparable in scope to Transform's surgical + non-surgical model, but with hospital-based delivery and broader geographic reach.
- WeightWatchers (WW): Long-established consumer weight management brand that has added a GLP-1 telehealth program (WW Clinic); a broader incumbent competing for the same behavioral and medical weight loss customers Transform serves.
- Eli Lilly (Lilly Direct / Mounjaro / Zepbound): Pharmaceutical manufacturer of tirzepatide (Mounjaro, Zepbound) prescribed through Transform; Lilly's direct-to-patient channels and pricing decisions materially shape the GLP-1 economics underpinning Transform's non-surgical offering.
Others
- Medtronic (bariatric/metabolic surgery): Medical device partner whose bariatric stapling and energy products are used in Transform's surgical procedures; an enabling ecosystem participant rather than direct competitor, shaping the equipment layer Transform builds on.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Transform Weight Loss social profiles
Digital presenceTransform Weight Loss financial estimates
Financial estimateRevenue estimate
Valuation estimate
Transform Weight Loss leadership team
Management profileNumber of profiles
Profiles9 records
Transform Weight Loss funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Transform Weight Loss M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Transform Weight Loss
What does Transform Weight Loss do?
Transform Weight Loss is a medical practice that provides a comprehensive spectrum of weight loss and wellness services to individuals, ranging from non-surgical medically-supervised programs (GLP-1 medications, biometric testing, nutritional consulting, supplements) and surgical bariatric procedures (gastric sleeve, gastric bypass, gastric balloon, Lap Band, SADI, and the proprietary MagnaSlim magnetic compression procedure) to cosmetic body contouring and gynecological/GI surgical services. Services are delivered at two Washington State clinics and an ambulatory surgery center, plus a telehealth platform (Transform at Home) for virtual consultations, medications, and ongoing coaching.
Is Transform Weight Loss a public or private company?
Transform Weight Loss is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Transform Weight Loss founded?
Transform Weight Loss was founded in 2018. It employs 1 to 10 people.
Where is Transform Weight Loss based?
Transform Weight Loss is headquartered in Kirkland, United States, in the North America region.
How does Transform Weight Loss make money?
Seven revenue lines are on record. Surgical Weight Loss Procedures are the primary driver. The others are non-Surgical Medical Weight Loss, weight Loss Medications, cosmetic Procedures, supplements, GYN Services and cherry Financing Partnership.
Who are Transform Weight Loss's main competitors?
Direct peers on record are Ro, Noom, Found, Calibrate and Hims & Hers Health. Broad incumbents are Novo Nordisk, NYU Langone Weight Management Program, WeightWatchers (WW) and Eli Lilly (Lilly Direct / Mounjaro / Zepbound). Medtronic (bariatric/metabolic surgery) is listed as an others.
Does Transform Weight Loss have an API?
No public API is recorded for Transform Weight Loss.
What industry is Transform Weight Loss in?
Transform Weight Loss's product category is Medical Weight Loss and Bariatric Surgery Services. Its primary akta.pro industry code is HLAKADAL, Obesity Medicine & Weight Management. Its NAICS code is 6211 and its SIC code is 8011.